Delivery Order SPE2DR25D1017-SPE2DR26F8ZPY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,069.43 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,541.93 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on April 24, 2025, with completion expected by April 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,883.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 24, 2025, with completion targeted for September 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $9,191.62 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, which is expected to be completed by November 7, 2025, was awarded competitively with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order valued at $14,500.79 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections (0.5 ml) on October 22, 2025, with an ultimate completion date of October 23, 2025. The contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors with a contract value of $1,063.47. This firm fixed-price delivery order, with a completion date of November 7, 2025, is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, consistent with AmerisourceBergen's standard federal...
- The Defense Logistics Agency awarded a delivery order valued at $9,747.92 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectables on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pen injectors valued at $7,226.22 with a firm fixed price structure. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing indefinite delivery contract vehicle. Performance will occur at the company's corporate office location in Conshohocken,...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZPYDelivery Order
The Defense Logistics Agency awarded a $5,450.56 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on November 14, 2025, with completion expected by November 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Mounjaro, a diabetes medication, represents one category of pharmaceutical products AmerisourceBergen routinely delivers through this contract vehicle to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/14/25 |